Related Experiment Videos
Serum ferritin. Screening test for colorectal cancer?
J H Scholefield1, M H Robinson, K Bostock
1Department of Surgery, University Hospital, Nottingham, United Kingdom.
Diseases of the Colon and Rectum
|August 26, 1998
Summary
Serum ferritin levels did not differ significantly between colorectal cancer patients and controls. This suggests serum ferritin is not a valuable tool for colorectal cancer screening.
Area of Science:
- Gastroenterology
- Oncology
- Biochemistry
Background:
- Colorectal cancer screening is gaining interest due to its life-saving potential.
- No perfect screening test currently exists for colorectal cancer.
- Serum ferritin levels may decrease before anemia in colorectal cancer patients, prompting investigation as a potential biomarker.
Purpose of the Study:
- To evaluate the utility of serum ferritin as a screening test for colorectal cancer.
- To determine if serum ferritin levels can differentiate between patients with and without colorectal cancer.
Main Methods:
- Serum samples from 148 patients were analyzed.
- Patients were categorized into three groups: proven colorectal cancer, no colon disease, and adenomas.
- Serum ferritin was measured using immunoradiometry.
Main Results:
- No statistically significant differences in serum ferritin levels were observed among the three patient groups.
- Serum ferritin assays showed no correlation with the presence or absence of colorectal cancer or adenomas.
Conclusions:
- Serum ferritin is unlikely to be a valuable screening test for colorectal cancer.
- Further research may be needed to identify more effective biomarkers for early colorectal cancer detection.